Monopar Therapeutics Stock Forecast

Stock Price Forecast

The 6 analysts that cover Monopar Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $59.6, which forecasts a 64.41% increase in the stock price over the next year. The lowest target is $40 and the highest is $76.

Price Target: $59.6 (+64.41%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$40	$59.6	$60	$76
Change	+10.34%	+64.41%	+65.52%	+109.66%

Analyst Ratings

The average analyst rating for Monopar Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '25	Feb '25	Mar '25	Apr '25	May '25	Jun '25
Strong Buy	3	3	3	3	3	3
Buy	1	1	2	2	2	2
Hold	0	0	0	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	5	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Keay Nakae Chardan Capital	Chardan Capital	Strong Buy Initiates $60	Strong Buy	Initiates	$60	+65.52%	Jun 23, 2025
Justin Walsh Jones Trading	Jones Trading	Strong Buy → Hold Downgrades n/a	Strong Buy → Hold	Downgrades	n/a	n/a	Apr 2, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $40	Strong Buy	Reiterates	$40	+10.34%	Apr 1, 2025
Biren Amin Piper Sandler	Piper Sandler	Buy Initiates $76	Buy	Initiates	$76	+109.66%	Mar 19, 2025
Sean Lee HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $22 → $40	Strong Buy	Maintains	$22 → $40	+10.34%	Jan 22, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 77.96M

Revenue Next Year

n/a

EPS This Year

-2.30

from -4.11

EPS Next Year

-4.39

from -2.30

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028	FY 2029
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028	Dec 31, 2029
Revenue	-	1.94M	25.13M	53.51M	77.96M
Revenue Growth	-	-	1,196.80%	112.90%	45.70%	-	-	-
EPS	-2.88	-3.65	-4.13	-3.04	-4.11	-2.30	-4.39	-0.47
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	6	5	5

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	4.0M	44.0M
Avg	n/a	1.9M	25.1M
Low	n/a	n/a	7.2M

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	2,170.1%
Avg	-	-	1,196.8%
Low	-	-	273.1%

EPS Forecast

EPS	2025	2026	2027
High	-1.74	-2.72	0.63
Avg	-2.30	-4.39	-0.47
Low	-2.51	-5.89	-1.49

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.